{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:55:14Z","timestamp":1774936514914,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":572,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To assess the immunoreactivity of malignant mesotheliomas for N\u2010 and E\u2010cadherins, hepatocyte growth factor\/scatter factor (HGF\/SF) and the tyrosine kinase receptors, met and erbB\u20102.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>Pleural malignant mesotheliomas were stained using a standard indirect immunoperoxidase method applied to paraffin sections. Malignant mesotheliomas were immunoreactive for N\u2010cadherin (26\/29; 90%), met (29\/29; 100%) and erbB\u20102 (28\/29; 97%). Focal immunoreactivity was present for E\u2010cadherin in epithelioid or mixed tumours (14\/25; 56%), and for HGF\/SF (9\/24; 38%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Expression of N\u2010cadherin supports the diagnosis of malignant mesothelioma and use of appropriate antibodies would be a useful addition to a diagnostic antibody panel. Focal staining for E\u2010cadherin does not exclude mesothelioma. Signalling pathways mediated via met and erbB\u20102 may play a role in the growth and spread of malignant mesotheliomas.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2559.2000.00888.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T00:09:19Z","timestamp":1047427759000},"page":"522-528","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Immunoreactivity for cadherins, HGF\/SF, met, and erbB\u20102 in pleural malignant mesotheliomas"],"prefix":"10.1111","volume":"36","author":[{"given":"I","family":"Thirkettle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P S","family":"Hasleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Y","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Warn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.5460776.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<369::AID-PATH460>3.0.CO;2-8"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90462-X"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90170-2"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1997.2150833.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1998.00349.x"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90302-X"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90171-4"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199612)180:4<389::AID-PATH685>3.0.CO;2-K"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910490302"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(97)10157-5"},{"key":"e_1_2_7_13_2","first-page":"165","article-title":"Clinical and pathological significance of the c\u2010erbB\u20102 (HER\u20102\/neu) oncogene","volume":"27","author":"Singleton TP","year":"1992","journal-title":"Pathol. Ann."},{"key":"e_1_2_7_14_2","unstructured":"TravisWD ColbyTV CorrinB ShimosatoY BrambillaE. and collaborators from 14 countries. World Health Organisation Pathology Panel: World Health Organisation.Histological Typing of Lung and Pleural Tumors. International Classification of Tumours 3rd edn. in press."},{"key":"e_1_2_7_15_2","unstructured":"HasletonPS. Pleural disease. In: Hasleton P ed.Spencer's Pathology of the Lung 5th edn. New York: McGraw\u2010Hill 1996:11311210."},{"key":"e_1_2_7_16_2","unstructured":"PignatelliM&VesseyCJ. Adhesion molecules and cancer. Chap. 8. In: Kirkham N Lemoine NR eds.Progress in Pathology Vol. 2. Edinburgh: Churchill Livingstone 1995 161175."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<1::AID-PATH135>3.0.CO;2-T"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004320050171"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.176"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.64"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.12.13.1267"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2303.1993.tb00090.x"},{"key":"e_1_2_7_23_2","first-page":"897","article-title":"Immunocytochemical analysis of oncoproteins and growth factors in human malignant mesotheliomas","volume":"2","author":"Susuki Y","year":"1995","journal-title":"Oncol. Reports"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2000.00888.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2559.2000.00888.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1046\/j.1365-2559.2000.00888.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:40:04Z","timestamp":1698572404000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2559.2000.00888.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1046\/j.1365-2559.2000.00888.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2559.2000.00888.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}